Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02755597 |
|---|---|
| Brief Title: | A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy (Bellini) |
| First Submitted : | April 20, 2016 |
| First Submitted that Met QC Criteria : | April 27, 2016 |
| First Posted : | April 29, 2016 (Estimate) |
| Results First Submitted : | July 12, 2023 |
| Results First Submitted that Met QC Criteria : | August 18, 2023 |
| Results First Posted : | August 22, 2023 |
| Certification/Extension First Submitted : | July 16, 2021 |
| Certification/Extension First Submitted that Met QC Criteria : | July 16, 2021 |
| Certification/Extension First Posted : | July 20, 2021 |
| Last Update Submitted that Met QC Criteria : | August 18, 2023 |
| Last Update Posted : | August 22, 2023 |